King discontinues Intal nebulizer solution
King Pharmaceuticals has decided to discontinue manufacturing Intal nebulizer solution (cromolyn sodium inhalation solution). The decision is based upon many factors, including the company's understanding of current medical therapy and the availability of alternative asthma therapies.
Intal nebulizer solution is a prophylactic agent indicated for the management of patients with bronchial asthma.
For more information call (800) 776-3637 or visit www.fda.gov/cder/drug/shortages/default.htm#Intal.